Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bull

Paradigm Therapeutics, Inc. South Carolina

View original content:https://www.prnewswire.com/news-releases/paradigm-therapeutics-inc-announces-an-additional-investment-by-eshelman-ventures-llc-to-expedite-global-development-and-global-registration-of-sd-101-a-topical-therapy-for-treatment-across-the-entire-skin-surface-of-all-subty-302483746.html